Affimed in the spotlight (part X)

Sourcing NK cells and partnerships

NK cell investigator from MD Anderson, Katy Rezvani, was on a podcast hosted by Statnews last week, where she discussed AFM13 data and the durability of NK cells. Listen to the talk here (Rezvani’s part starts at 14 min mark).
 
Rezvani was optimistic about the overall NK cell therapy space. The safety data that has been presented thus far is promising an…